BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 27025360)

  • 1. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
    Vinholt PJ; Alnor A; Nybo M; Hvas AM
    Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
    Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
    Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of platelet transfusion within the Wellington Cancer Centre.
    Buhrkuhl DC; Karlsson MK; Carter JM
    Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
    Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
    N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
    Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD
    Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-induced platelet reactivity correlates with bleeding in haemato-oncological patients.
    Batman B; van Bladel ER; van Hamersveld M; Pasker-de Jong PCM; Korporaal SJA; Urbanus RT; Roest M; Boven LA; Fijnheer R
    Vox Sang; 2017 Nov; 112(8):773-779. PubMed ID: 28960383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes.
    Mo A; Wood E; Shortt J; Hu E; McQuilten Z
    Eur J Haematol; 2023 Oct; 111(4):592-600. PubMed ID: 37452616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks.
    Cornelissen LL; Caram-Deelder C; Fustolo-Gunnink SF; Groenwold RHH; Stanworth SJ; Zwaginga JJ; van der Bom JG
    Transfusion; 2021 Sep; 61(9):2578-2587. PubMed ID: 34263930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
    Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T
    Vox Sang; 2017 Aug; 112(6):578-585. PubMed ID: 28639693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
    Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
    Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function tests predict bleeding in patients with acute myeloid leukemia and thrombocytopenia.
    Just Vinholt P; Højrup Knudsen G; Sperling S; Frederiksen H; Nielsen C
    Am J Hematol; 2019 Aug; 94(8):891-901. PubMed ID: 31119762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
    Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
    Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
    Callow CR; Swindell R; Randall W; Chopra R
    Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Platelet Transfusions for Critically Ill Patients With Thrombocytopenia: A Single-Institution Propensity-Matched Cohort Study.
    Warner MA; Chandran A; Frank RD; Kor DJ
    Anesth Analg; 2019 Feb; 128(2):288-295. PubMed ID: 29293185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of lower neonatal platelet transfusion thresholds.
    Hasan R; Saifee NH
    Transfusion; 2021 Jun; 61(6):1672-1675. PubMed ID: 33786866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.